Term amniotic fluid: an unexploited reserve of mesenchymal stromal cells for reprogramming and potential cell therapy applications. Stem Cell Res Ther. 2017 Aug 25;8(1):190. doi: 10.1186/s13287-017-0582-6. PMID: 28841906; PMCID: PMC5574087
Mesenchymal Stromal Cell Therapy Regenerates Rejected Donor Lungs and Reduces Primary Graft Dysfunction Following Lung Transplantation Abstract Only. J Heart Lung Transplant. 2022 Apr; 41(4): S19
Neonatal MSCs from term amniotic fluid can be produced in large amounts in serum-free conditions without loss of stem cell properties Poster presented at Stem cell, Cell therapies and bioengineering in Lung biology and disease conference Vermont 15-18 July 2019
Extracellular vesicles derived from amniotic fluid mesenchymal stem cells selected by skin tissue type markers reduce inflammation Cytotherapy Vol. 24 Issue 5 Supplement S89–S90 Published in issue: May, 2022
Lung tissue type selected amniotic fluid derived mesenchymal stem cells for treatment of bleomycin induced pulmonary fibrosis in a rat model Cytotherapy Vol. 24 Issue 5 Supplement S68 Published in issue: May, 2022
Pyruvate metabolism guides definitive lineage specification during hematopoietic emergence EMBO Rep. 2022 Feb 3;23(2):e54384. doi: 10.15252/embr.202154384. Epub 2021 Dec 16. PMID: 34914165; PMCID: PMC8811648.
Amniotic Fluid Mesenchymal Stem Cells Selected for Neural Specificity Ameliorates Chemotherapy Induced Hearing Loss and Pain Perception ICRBE 2022: 16. International Conference on Regenerative Biology and Engineering July 28-29, 2022 in Zurich, Switzerland